| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.287 | 4.627 | 4.702 | 7.732 | 6.310 | 14.960 | 59.243 | 19.682 | 17.007 | 0 |
| Total Income - EUR | 3.287 | 4.627 | 4.702 | 7.732 | 6.310 | 14.960 | 78.600 | 19.682 | 17.010 | 0 |
| Total Expenses - EUR | 2.010 | 5.913 | 7.992 | 4.190 | 1.053 | 3.839 | 19.532 | 3.171 | 4.857 | 0 |
| Gross Profit/Loss - EUR | 1.277 | -1.286 | -3.290 | 3.542 | 5.257 | 11.122 | 59.068 | 16.511 | 12.153 | 0 |
| Net Profit/Loss - EUR | 1.179 | -1.384 | -3.337 | 3.334 | 5.068 | 10.702 | 57.325 | 15.976 | 11.983 | 0 |
| Employees | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Clorophilla Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.556 | 3.039 | 1.038 | 0 | 563 | 1.744 | 724 | 0 | 0 | 0 |
| Current Assets | 983 | 1.071 | 1.225 | 2.031 | 4.601 | 14.255 | 75.201 | 19.987 | 12.129 | 188 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 551 | 98 | 250 | 2.561 | 10.685 | 59.359 | 16.975 | 11.928 | 0 |
| Cash | 983 | 519 | 1.127 | 1.782 | 2.040 | 3.570 | 15.842 | 3.012 | 201 | 188 |
| Shareholders Funds | 3.364 | 1.946 | -1.424 | 1.936 | 5.118 | 10.834 | 57.471 | 16.122 | 12.129 | 188 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 124 | 121 | 122 | 121 | 121 |
| Debts | 175 | 2.164 | 3.687 | 96 | 47 | 3.165 | 18.454 | 3.865 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6220 - 6220" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Clorophilla Research S.r.l.